RxDoctor Payments Data

Vanna Altman

Family · Winchester, MANPI 1669576922

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 95.7% of the total across 600 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 25 manufacturers, the largest accounting for just 22.7% — the pattern of someone who eats at a lot of different presentations. Among family clinicians in MA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$15,639in general payments, 2019–2025

Across 600 payments — averaging $26.06 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Johnson & Johnson$4K
  • AbbVie$2K
  • E.r. Squibb & Sons, L.L.C.$1K
  • Lilly USA, LLC$1K
  • Lumenis BE Inc$1K
  • UCB, Inc.$1K
  • plus $6K from 19 others

What the payments were for

  • Food & beverage$14,96996%
  • Education$6704%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$15,639 in reported general payments places this provider in the 95th percentile of 2,320 family providers in Massachusetts.

See all family providers in Massachusetts

Medicare billing

Part B allowed, 2024
$39,134
Medicare patients
204
Services billed
1,134

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Fluorouracil49$2,506
Ketoconazole91$1,825
Triamcinolone Acetonide74$1,100
Clobetasol Propionate16$990
Betamethasone Dipropionate29$967
Metronidazole20$847
Mupirocin27$200
Doxycycline Hyclate12$137
Hydrocortisone13$101

Paid to pharmacies, not to this prescriber.

Other family in Winchester

See the full list for Massachusetts

Where these figures come from

Is this you, or does something look wrong? →